The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity

被引:80
作者
You, Tongjian [1 ]
Nicklas, Barbara J. [2 ]
Ding, Jingzhong [2 ]
Penninx, Brenda W. J. H. [3 ,4 ]
Goodpaster, Bret H. [5 ]
Bauer, Douglas C. [6 ,7 ]
Tylavsky, Frances A. [8 ]
Harris, Tamara B.
Kritchevsky, Stephen B. [2 ,9 ]
机构
[1] SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14214 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Sticht Ctr Aging, Winston Salem, NC USA
[3] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands
[5] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15260 USA
[6] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[7] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA
[8] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA
[9] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA
来源
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES | 2008年 / 63卷 / 04期
关键词
metabolic syndrome; adipokines; adiposity; aging;
D O I
10.1093/gerona/63.4.414
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background. Circulating levels of adipokines are elevated with adiposity and are closely linked with the clustering of traditional metabolic risk factors for cardiovascular disease. The purpose of this study was to examine the relationship of metabolic syndrome to several adipokines and the role of total and visceral adiposity in influencing this relationship in older adults. Methods. A cross-sectional analysis was conducted including 1914 individuals aged 70-79 years without cardiovascular disease or type 2 diabetes. The metabolic syndrome was defined by the updated Adult Treatment Panel III criteria. Circulating levels of leptin, adiponectin, plasminogen activator inhibitor type 1 (PAI-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and C-reactive protein (CRP) were measured. Body composition and abdominal visceral fat area were determined. Results. Both the presence of metabolic syndrome and the number of metabolic syndrome components were associated with higher levels of leptin, PAI-1, IL-6, TNF-a, and CRP and with lower levels of adiponectin (all p < .0001). The odds ratios for the prevalence of metabolic syndrome associated with adipokines were attenuated after adjustment for total fat mass and/or visceral fat area, but remained significant. Levels of leptin, PAI-1, IL-6, and TNF-alpha were higher (all p < .05 to p < .0001), and adiponectin was lower (all p < .0001), in persons with, compared to those without, metabolic syndrome within each tertile of percent body fat. Conclusion. The metabolic syndrome is associated with adipokines in older adults across a wide range of adiposity, including in those with low or normal overall fatness.
引用
收藏
页码:414 / 419
页数:6
相关论文
共 31 条
[1]   Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample [J].
Ahluwalia, N. ;
Drouet, L. ;
Ruidavets, J. -B. ;
Perret, B. ;
Amar, J. ;
Boccalon, H. ;
Hanaire-Broutin, H. ;
Ferrieres, J. .
ATHEROSCLEROSIS, 2006, 186 (02) :345-353
[2]   Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease [J].
Alessi, MC ;
Peiretti, F ;
Morange, P ;
Henry, M ;
Nalbone, G ;
JuhanVague, I .
DIABETES, 1997, 46 (05) :860-867
[3]  
Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198
[4]  
Bahia Luciana, 2006, Clinics, V61, P433, DOI 10.1590/S1807-59322006000500010
[5]   What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? [J].
Brochu, M ;
Tchernof, A ;
Dionne, IJ ;
Sites, CK ;
Eltabbakh, GH ;
Sims, EAH ;
Poehlman, ET .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1020-1025
[6]   Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome [J].
Choi, K. M. ;
Ryu, O. H. ;
Lee, K. W. ;
Kim, H. Y. ;
Seo, J. A. ;
Kim, S. G. ;
Kim, N. H. ;
Choi, D. S. ;
Baik, S. H. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 75 (02) :235-240
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]   Association of low interleukin-10 levels with the metabolic syndrome in obese women [J].
Esposito, K ;
Pontillo, A ;
Giugliano, F ;
Giugliano, G ;
Marfella, R ;
Nicoletti, G ;
Giugliano, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) :1055-1058
[9]   Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and Adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans [J].
Fain, JN ;
Madan, AK ;
Hiler, ML ;
Cheema, P ;
Bahouth, SW .
ENDOCRINOLOGY, 2004, 145 (05) :2273-2282
[10]   Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid [J].
Fried, SK ;
Bunkin, DA ;
Greenberg, AS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :847-850